Autopsy report · NCT03461458

Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease

“Principal Investigator transition”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Degenerative Disc Disease

Interventions

Autologous Adipose-Derived Mesenchymal Stromal Cells

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
  “Departure of the Principal Investigator” (82% match in meaning)
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
  “Principal Investigator's departure” (81% match in meaning)
• Changes in Muscle Activation When Carrying Backpacks
  “Change of a principal investigator” (80% match in meaning)
• Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion
  “Departure of the principal investigator and lack of succession” (77% match in meaning)
• Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
  “departure of the principal investigator without replacement” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.